← Back to all trials
Not Yet Recruiting
NCT05624320
Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses
Conditions: Presbyopia
Sex: All
Ages: 40 Years – 55 Years
Healthy volunteers: 1
Phase: PHASE4
Enrollment: 30
Sponsor: Gordon Schanzlin New Vision
Summary
AGN-190584 has gone through many clinical trials showing its safety and effectiveness in individuals from 40-55 years of age.
There has been no published data on the use of this product in individuals corrected with contact lenses for distance vision.
There are many other applications AGN-190584 could be used for and further studies will show the effectiveness for each.
Eligibility Criteria
Inclusion Criteria:Subjects from age 40-55Prescription range: -4.00 - +1.00Correctable to 20/25 or better for distanceAdapted single use contact lens patientsSubjects able to understand the consent agreement and willing to participateExclusion Criteria:Non-contact lens wearerPrevious use of AGN-190584Out of age rangeOut of prescription rangeAny corneal abnormalityAny eye pathologyIritisKnow allergy to pilocarpine
Source: ClinicalTrials.gov (NCT05624320). StuddyBuddy aggregates publicly available trial information.
